Integrin-mediated death: An explanation of the integrin-knockout phenotype? [1]

Nature Medicine

Volumn 8, Issue 3, 2002, Pages 193-194

  Cheresh, David A ^a   Stupack, Dwayne G ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; ANGIOGENESIS INHIBITOR; ANGIOSTATIN; BETA3 INTEGRIN; CASPASE 8; COLLAGEN TYPE 4; ENDOSTATIN; INTEGRIN; RETINA S ANTIGEN; TUMSTATIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; CANCER; CELL DEATH; CELL SURVIVAL; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GLANZMANN DISEASE; GROWTH REGULATION; HUMAN; HUMAN CELL; KNOCKOUT GENE; LETTER; LIGAND BINDING; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS;

ANIMALS; APOPTOSIS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; RECEPTORS, VITRONECTIN;

EID: 0036130826     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0302-193     Document Type: Letter

References (9)

1. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
2. Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel
3. Integrin indecision
4. v integrin antagonists: Comparative anti-cancer efficacy with known angiogenesis inhibitors
5. 3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
6. 5 integrins
7. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins
8. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin
9. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis